Tulip Diagnostics Private Limited - Due diligence report

A 360° intelligence report on Tulipgroup: trust score, financial health, credit view, compliance, directors, growth and distress signals - g…

1988-12-14 Tiswadi, Goa Active Unlisted Active Compliant
Share
TD Tulip Diagnostics Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Tulipgroup — 360° Intelligence Report

Generated from MCA filings & public records
77/100
Trust Score
Low Risk

Tulipgroup is assessed as Low Risk with a Trust Score of 77/100. Tulipgroup is an active private limited indian non-government company incorporated in 1988, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Tulip Diagnostics Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
66/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
65/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 12 satisfied (2.73 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Bank Of India11 48.0 cr
Panaji Branch1 48.0 cr
Compliance Score: 66/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 2 court forum(s).
  • Delayed payments to MSME suppliers disclosed (10 disclosure(s)).
  • 5 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
ALOK KUMAR 01234567 Director 01/04/2018 6 yrs Approved
NARENDRA MAKKAR 01234567 Director 01/04/2018 6 yrs Approved
DEEPAK GURUSHANKAR TRIPATHI 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Perkinelmer Holding Luxembourg S.a R.l
Subsidiaries
3
Group entities
3
Capital events
3 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Singapore Biosciences Pte. Ltd. Subsidiary Company 74.00%
Biosense Technologies Private Limited Subsidiary Company 74.00%
Orchid Biomedical Systems Private Limited Subsidiary Company 74.00%
Prisms India Private Limited Subsidiary Company 74.00%
Pt Tulip Diagnostics Indonesia Subsidiary Company 74.00%
Perkinelmer Holding Luxembourg S.a R.l Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 75
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
Profit expanded 24% year-on-year.
Net margin improved to 0.86.
Operating for 37+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
MSME payment delays disclosed - latest outstanding 2.85 cr.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence72/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment58/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view72/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
17 Feb 2022
Securities allotted
15250 Equity Shares - 14.99 cr raised
30 Jun 2021
Director ceased
DAISY YIK YAN AUYEUNG
30 Sep 2020
Director ceased
NARENDRANATH SHARATCHANDRA BHAT
08 Jul 2020
Director ceased
JAYASHREE KAILAS THACKER
25 Oct 2019
Securities allotted
48400 Equity Shares - 60.50 cr raised
29 Sep 2017
Director ceased
NARENDRA MAKKAR
19 Sep 2017
Director appointed
NARENDRA MAKKAR (Director)
05 May 2017
Director appointed
DEEPAK GURUSHANKAR TRIPATHI (Director)
31 Jan 2017
Director appointed
ALOK KUMAR (Director)
Director ceased
VINAYAK KASHINATH NAIK
Director ceased
SRIRAM NATARAJAN
Director ceased
ALOK KUMAR
Director ceased
DEEPAK GURUSHANKAR TRIPATHI
10

Key Observations

Auto-generated from the data above
Revenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - leverage worth monitoring.
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
5 active GST registration(s) indicate ongoing business operations.
All 12 registered charge(s) stand satisfied - past borrowings repaid.
Operates a group structure with 3 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
3 overseas direct investment(s) (ODI) on record - international footprint.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Oriental Carbon & Chemicals L64990GJ1978PLC133845 Mundra, Gujarat, India
Piyanshu Chemicals Pvt Ltd U24231WB1992PTC055683 Kolkata, West Bengal, India
Associate Allied Chemicals (India) Private Limited U24110MH1995PTC089749 Mumbai, Maharashtra, India
Bhimani Chemicals Private Limited U24114GJ2001PTC039432 Ahmedabad, Gujarat, India
Alivira U74120MH2013PLC248708 Mumbai, Maharashtra, India
Rsh Global U20237WB2005PTC103808 Kolkata, West Bengal, India
Scott Edil Pharmacia Limited U24232CH2003PLC025699 Chandigarh, Chandigarh, India
Satyesh Brinechem U24100GJ2014PTC078780 Ahmedabad, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Tulipgroup before audits and certifications: compliance score 66/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Tulipgroup: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Tulipgroup - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Tulipgroup pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Tulipgroup - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Tulipgroup an active company?

Tulipgroup has MCA status “Active” with a compliance score of 66/100 (Moderate).

Is Tulipgroup financially healthy?

Tulipgroup has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.

Should I do business with Tulipgroup?

Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Tulipgroup?

The ultimate holding entity is Perkinelmer Holding Luxembourg S.a R.l. 3 active director(s) are on record.

Does Tulipgroup have loans or charges against its assets?

No open charges - all 12 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Tulipgroup up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 66/100 (Moderate).

Is it risky to lend to Tulipgroup?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.